+46.1%
GSK vs QSR
+25.0%
+21.1%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | QSR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.7% | -0.4% | -0.9% |
| 7D | -5.4% | -4.7% | -0.7% | -4.3% |
| 30D | -4.6% | +4.3% | -8.9% | -5.6% |
| 3M | -5.1% | +5.4% | -10.6% | -6.3% |
| 6M | -11.4% | +8.2% | -19.6% | -13.2% |
| YTD | +0.7% | +14.1% | -13.4% | -2.7% |
| 1Y | +23.0% | +28.1% | -5.1% | +15.6% |
| All | +46.1% | +25.0% | +21.1% | +37.6% |
Cumulative growth
Daily Returns
Daily percentage return beside QSR.
Daily Out/Under-Performance
Portfolio return minus QSR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QSR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded QSR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling